Skip to main content
SpringerLink
Log in

The role of hypertension in cyclosporine-induced hyperuricemia

  • Clinical Trials Report
  • Published:
Current Rheumatology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Merion RM, Guidinger MK, Newmann JM, et al.: Prevalence and outcomes of multiple-listing for cadaveric kidney and liver transplantation. Am J Transplant 2004, 4:94–96.

    Article  PubMed  Google Scholar 

  2. Hariharan S, Johnson CP, Bresnahan BA, et al.: Improved graft survival after renal transplantions in the United States, 1988 to 1996. N Engl J Med 2000, 342:605–612.

    Article  PubMed  CAS  Google Scholar 

  3. Clive DM: Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol 2000, 11:974–979.

    PubMed  CAS  Google Scholar 

  4. Simkin PA, Gardner GC: Colchicine use in cyclosporine treated transplant recipients: how little is too much? J Rheumatol 2000, 27:1334–1337.

    PubMed  CAS  Google Scholar 

  5. Sica DA, Schoolwerth AC: Part 1: uric acid and losartan. Curr Opin Nephrol Hypertens 2002, 11:475–482.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Jeffrey Bieber MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Terkeltaub MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bieber, J., Terkeltaub, R. The role of hypertension in cyclosporine-induced hyperuricemia. Curr Rheumatol Rep 6, 215–216 (2004). https://doi.org/10.1007/s11926-004-0070-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11926-004-0070-8

Keywords

Search

Navigation